Decreased HIV transmission after a policy of providing free access to highly active antiretroviral therapy in Taiwan

被引:199
作者
Fang, CT
Hsu, HM
Twu, SJ
Chen, MY
Chang, YY
Hwang, JS
Wang, JD [1 ]
Chuang, CY
机构
[1] Natl Taiwan Univ, Coll Publ Hlth, Taipei 100, Taiwan
[2] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan
[3] Execut Yuan, Dept Hlth, Taipei, Taiwan
[4] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan
关键词
D O I
10.1086/422601
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Taiwan established a nationwide surveillance system for human immunodeficiency virus (HIV) infection in 1989 and adopted a policy to provide all HIV-infected citizens with free access to highly active antiretroviral therapy ( HAART) beginning in April 1997. This provided an opportunity to determine the effect of the widespread use of HAART on the evolution of the HIV epidemic. Methods. We analyzed national HIV surveillance data. The HIV transmission rate was estimated by use of an exponential model of HIV epidemic evolution, with statistical projection over the interval between infection and detection to fit the surveillance data. Results. By the end of 2002, the cumulative number of HIV-infected citizens in Taiwan had reached 4390 (0.019% of the total population). After free access to HAART was established, the estimated HIV transmission rate decreased by 53% (0.391 vs. 0.184 new cases/prevalent case-year [95% confidence interval, 31%-65%]). There was no statistically significant change in the incidence of syphilis, in the general population or among HIV-positive patients, during the same period. Conclusion. Providing free HAART to all HIV-infected citizens was associated with a 53% decrease in the HIV transmission rate and contributed to the control of the HIV epidemic in Taiwan.
引用
收藏
页码:879 / 885
页数:7
相关论文
共 38 条
[1]   POTENTIAL OF COMMUNITY-WIDE CHEMOTHERAPY OR IMMUNOTHERAPY TO CONTROL THE SPREAD OF HIV-1 [J].
ANDERSON, RM ;
GUPTA, S ;
MAY, RM .
NATURE, 1991, 350 (6316) :356-359
[2]  
[Anonymous], 1992, MMWR Recomm Rep, V41, P1
[3]  
[Anonymous], 1998, MMWR-MORBID MORTAL W, V47, P1
[4]   We all have AIDS: case for reducing the cost of HIV drugs to zero [J].
Berwick, D .
BRITISH MEDICAL JOURNAL, 2002, 324 (7331) :214-216
[5]   A tale of two futures: HIV and antiretroviral therapy in San Francisco [J].
Blower, SM ;
Gershengorn, HB ;
Grant, RM .
SCIENCE, 2000, 287 (5453) :650-654
[6]  
Bracewell RN, 2000, FOURIER TRANSFORM IT, P126
[7]  
BROOKMEYER R, 1986, LANCET, V2, P1320
[8]   A METHOD FOR OBTAINING SHORT-TERM PROJECTIONS AND LOWER BOUNDS ON THE SIZE OF THE AIDS EPIDEMIC [J].
BROOKMEYER, R ;
GAIL, MH .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1988, 83 (402) :301-308
[9]  
BROOKMEYER R, 1994, AIDS EPIDEMIOLOGY QU, P194
[10]   Antiretroviral therapy in adults - Updated recommendations of the International AIDS Society-USA Panel [J].
Carpenter, CCJ ;
Cooper, DA ;
Fischl, MA ;
Gatell, JM ;
Gazzard, BG ;
Hammer, SM ;
Hirsch, MS ;
Jacobsen, DM ;
Katzenstein, DA ;
Montaner, JSG ;
Richman, DD ;
Saag, MS ;
Schechter, M ;
Schooley, RT ;
Vella, S ;
Yeni, PG ;
Volberding, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (03) :381-390